Company news: Bod Science; Emyria by Martin Lane November 21, 2023November 22, 2023 Bod Science has yet to settle tranche one of its current capital raise following delays in […]
Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health by Martin Lane November 14, 2023November 14, 2023
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Company news: Setek Therapeutics; Emyria; Melodiol Global Health by Martin Lane October 9, 2023October 12, 2023
Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023October 3, 2023
Emyria completes acquisition of Pax Centre for A$1.7m by Martin Lane September 13, 2023September 13, 2023
Company news: Health House; Little Green Pharma; Incannex; Emyria by Steve Jones and Martin Lane April 19, 2023April 19, 2023
Company news: Delta 9 Cannabis; Little Green Pharma; Zelira Therapeutics; Emyria by Martin Lane and Steve Jones February 16, 2023February 16, 2023
Company news: LGP; Cann Global; Medcan; Incannex; Medlab; Emyria; RestoreMe; Releaf Group; Levin Health by Martin Lane and Steve Jones November 30, 2022December 1, 2022
